Despite pandemic, economic rollercoaster, nasty politics and a host of other challenges faced, things are looking brighter in delightful La […]
University of Texas MD Anderson Cancer Center researchers along with a colleague from Genentech (Roche) and Seoul National University in […]
NeuroGenesis and Hadassah Medical Center announced highly positive results from a placebo-controlled Phase 2 clinical trial assessing the impact of […]
TG Therapeutics announced positive topline results from two global, active-controlled, Phase 3 studies, called ULTIMATE I & II, evaluating ublituximab […]
Gilead announced topline results from the Phase 2/3 CAPELLA trial evaluating lenacapavir versus placebo in heavily treatment-experienced patients with multidrug […]
The National Cancer Institute (NCI) injected $2.6 million into research involving two studies led by Case Western Reserve University and […]
Preliminary data from a phase 1 study, designed to evaluate the safety and efficacy of a personalized cancer vaccine in […]
Arena Pharmaceuticals announced topline results from the Phase 2b ADVISE clinical trial evaluating etrasimod for the treatment of moderate-to-severe atopic […]
Bristol-Myers Squibb reported positive results from POETYK PSO-1, the first pivotal Phase 3 trial evaluating deucravacitinib (BMS-986165) versus Otezla (apremilast) […]
Biogen announced positive data from the 24-week systemic lupus erythematosus (SLE) portion of the Phase 2 LILAC study (part A) […]
